Results 181 to 190 of about 4,371,559 (314)
Cytochrome bd Oxidase Has an Important Role in Sustaining Growth and Development of Streptomyces coelicolor A3(2) under Oxygen-Limiting Conditions [PDF]
Marco Fischer +3 more
openalex +1 more source
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Analysis of qPCR Data: From PCR Efficiency to Absolute Target Quantity. [PDF]
Ruijter JM, van den Hoff MJB.
europepmc +1 more source
Foreign Aid and the Poverty Trap: Increasing Aid Effectiveness by Limiting [PDF]
Yuchen Feng, Luying Meng, Yatong Lv
openalex +1 more source
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Limiting the Accretion-fed Growth of Neutron Stars during Common Envelope [PDF]
Morgan MacLeod, E. Ramírez-Ruiz
openalex
Limiting distributions of generalized money exchange models [PDF]
Hironobu Sakagawa
openalex +1 more source
Use of the Neodymium‐YAG laser to manage subinternal limiting membrane haemorrhage [PDF]
Peter Chau, Joseph Reich
openalex +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source

